.svg){kind=icon}
Health systems strengthening
We strengthen health systems by combining data, digital innovation, workforce development, and strategic partnerships.
Tackling global health challenges
Combining local expertise and data-driven insights, we develop and implement sustainable solutions tailored to local challenges and opportunities.
Health security, pandemic preparedness and AMR
We support integrated surveillance and clinical research innovation to respond rapidly to outbreaks and combat antimicrobial resistance.
Health access
We accelerate access to essential and breakthrough medical products through market access expertise, care optimisation strategies, partnerships and policy shaping.
IQVIA capabilities in global health
Health financing
High out-of-pocket costs, fragmented health financing and limited insurance coverage, hinders progress toward universal health coverage and equitable access to care.
IQVIA partners with governments and organizations to design, implement, and optimize health financing models that drive progress toward universal health coverage (UHC).
Our expertise spans actuarial modelling, benefit package design, insurance scheme implementation, and digital solutions for claims and beneficiary management. We leverage data-driven insights to ensure financial sustainability, equitable access, and improved health outcomes.
Evidence generation, analytics and clinical research
Fragmented health data, limited surveillance capacity, and slow research translation, hinder timely, evidence-based responses to emerging health threats and policy development.
IQVIA is a global leader in generating high-quality health data, advanced analytics, and clinical research. We design and implement surveillance systems, real-world evidence studies, and clinical trials, leveraging digital platforms and local expertise. Our solutions enable robust decision-making, policy development, and rapid response to emerging health threats.
Human resources for health
Skilled health workforce shortages is a critical Global Health concern: the WHO recommends 44.5 per 10,000 people. In Africa, the average is just 2 doctors and 10 nurses/midwives per 10,000.
IQVIA strengthens health systems by building local workforce capacity, optimizing recruitment, and delivering targeted training. We conduct comprehensive HRH assessments, develop capacity-building strategies, and support workforce planning to address shortages and enhance service delivery - especially in underserved regions. Through our clinical trials work, we empower, onboard, and mentor clinical trial sites, enabling them to deliver high-quality research, raise care standards, and expand access for the communities they serve.
Digital health and technology solutions
Fragmented digital infrastructure, lack of interoperability, and limited data governance impede the effective use of digital health solutions and the realization of universal health coverage.
IQVIA accelerates digital transformation in global health through interoperable platforms, electronic medical records (EMRs), health information exchanges, and AI-driven analytics. We design and implement national digital health blueprints, support data integration, and enable real-time monitoring for improved care delivery and system resilience.
IQVIA Global Health
Our vision for global health
Our vision is to advance healthcare everywhere by transforming data and local insights into scalable and sustainable solutions, delivered with trusted partners globally and in low‑ and middle‑income countries.
Making an impact through collaboration
IQVIA is working with The Global Fund and (RED) to strengthen healthcare in low- and middle-income countries, especially in Africa. Projects like the Data Science Catalytic Fund, launched with Rwanda, aim to drive innovation and speed up disease outbreak response. Through collaboration and technology, IQVIA is helping tackle global health challenges.
Use cases in global health
Pandemic preparedness
IQVIA is working with Europe’s Health Emergency Preparedness and Response Authority (HERA), harnessing data to better identify and respond to future health threats.
The role of data in pandemic preparedness.
Avoiding potential health emergencies requires development, production and distribution of medical countermeasures (MCM), including medicines, vaccines, diagnostic tests, and masks. HERA also has a coordination role, working with European Member States and agencies including the European Centre for Disease Prevention and Control and the European Medicines Agency. Together they gather data on health threats, European stocks of MCM and relevant response capabilities.
The Advanced Technology for Health Intelligence and Action IT system (Athina) is critical in bringing together intelligence on Europe’s pandemic preparedness. IQVIA helped define the appropriate real-world datasets to track MCM supply chains. We are also enabling the tracking of MCM shortages and identification of potential vulnerabilities and strategic dependencies, giving HERA the insight it needs to strengthen Europe’s future response.
Mpox: accelerating vaccine development in a growing health crisis
IQVIA is working closely with partners in the region to identify and develop appropriate and effective responses.
Since 2022, there has been a steady increase in mpox cases and deaths in the Democratic Republic of the Congo (DRC), which in 2024 spread to multiple countries and developed into a full-scale healthcare emergency. Vaccinations are a powerful tool to prevent infection and control disease spread. As part of efforts to develop a new mpox vaccine, we partnered with a major pharmaceutical company to rapidly launch effectiveness trials during the outbreak. Using our GRAM (Geographic Risk Assessment and Mitigation) approach, we identified trial sites in Kinshasa and Goma, DRC, accelerating vaccine development.
Using data and insight to address AMR
Antimicrobial resistance (AMR) is a growing public health concern that requires a collaborative and coordinated global response with local ownership.
Improve surveillance to address a global threat.
In September 2024, the UN General Assembly convened leaders from politics, healthcare, and life sciences to set new goals and actions to address antimicrobial resistance (AMR).
The University of Liverpool’s Civic Health Innovation Labs, funded by the UK Office for Life Sciences, is developing an antimicrobial learning system using IQVIA’s Health Analytics Network to improve antibiotic prescribing practices and reduce resistance. IQVIA also built a customizable forecast model to estimate demand for injectable antibiotics, validated in eight countries and adaptable for use in low- and middle-income regions.
Marburg: enhancing the world’s readiness to rapidly implement life-saving clinical research for vaccines
When the Ministry of Health of Rwanda declared an outbreak of Marburg virus disease (MVD) in Rwanda in September 2024, IQVIA was able to support the Rwandan government, CEPI, the Sabin Vaccine Institute and other partners to move rapidly to dose the first patient in a new clinical trial for MVD vaccine only ten days after the outbreak was declared.
The role of strategic partnerships to act fast.
In conjunction with national and regional collaborators, IQVIA and the Coalition for Epidemic Preparedness Innovations (CEPI) are working to enhance the world’s preparedness to rapidly conduct life-saving clinical research for vaccines and other biological countermeasures against emerging infectious diseases.
Furthermore, in the following nine days after the first patient, the coalition of partners supported the enrollment of an additional 700 subjects in the trial. This speed was facilitated by the years of investment we have made establishing relationships, local talent and technical capabilities in Africa and due to strategic partnerships already in place with CEPI and the Government of Rwanda.
About IQVIA’s global health mission
We help people live longer, healthier lives by advancing clinical research, delivering healthcare insights, and improving decisions through data, prioritizing impact in regions with limited access to high quality care.
We combine data science, technology, and healthcare expertise to strengthen health systems and support lifesaving public health initiatives.
IQVIA works across Africa, Asia, Latin America, Europe, North America, and other low- and middle-income regions to expand access and resilience.
We collaborate with governments and health organizations to detect, monitor, and respond to outbreaks using advanced analytics and real-world evidence.
Through partnerships with NGOs, ministries of health, and international agencies, we deliver fast, data-driven strategies to respond to health emergencies.
We apply innovative tools like AI, mobile health apps, and predictive modeling to accelerate clinical research and improve care delivery.
Technology enables faster, more informed decision-making and helps personalize treatments and scale health interventions efficiently.
Our collaborations span governments, NGOs, philanthropic groups, and international organizations with a shared goal of advancing global health.